Ahmedabad— AUGUST 21, 2026 — ABH Healthcare Limited, which operates Punjab’s NABHaccredited multi-specialty tertiary care hospital, Anil Baghi Hospital, today announced the opening of its Initial Public Offering (IPO) on Monday, August 24, 2026. The company plans to raise up to ₹34.98 crore through a fresh issue of 34,29,600 equity shares on the NSE SME (Emerge) platform. The issue price band has been fixed at ₹96 to ₹102 per equity share. The bidding window will remain open until Thursday, August 27, 2026. The allotment of shares is expected to be finalized on Friday, August 28, 2026, with the tentative listing set for Tuesday, September 1, 2026. Net proceeds from the fresh issue will be utilized to strengthen the company’s financial structure and fund expansion. Specifically, the company has allocated ₹17.00 crore towards the prepayment or repayment of certain outstanding borrowings, in full or in part. Additionally, ₹5.00 crore will be deployed toward funding core working capital requirements, while the remaining balance will support strategic inorganic growth opportunities and general corporate purposes. For retail investors, the minimum application size is set at 2 lots (2,400 shares), amounting to ₹2,44,800 at the upper price band, while High Net-Worth Individuals (HNIs) must apply for a minimum of 3 lots (3,600 shares), requiring an investment of ₹3,67,200. On the financial front, ABH Healthcare Limited has demonstrated consistent top-line and bottom-line growth over recent years, supported by strong operating metrics. The company’s total income expanded from ₹41.39 crore in FY24 to ₹49.32 crore in FY25, ultimately reaching ₹52.59 crore in FY26. Operating profitability saw a significant increase as EBITDA grew from ₹6.89 crore in FY24 to ₹13.20 crore in FY25, expanding further to ₹14.72 crore in FY26 with a healthy EBITDA margin of 28.03%. Profit After Tax (PAT) experienced robust multi-year growth, climbing from ₹1.66 crore in FY24 to ₹5.35 crore in FY25 and reaching ₹5.64 crore in FY26 with a PAT margin of 10.74%. The company maintains strong equity performance, delivering a Return on Equity (ROE) of 39.07% alongside a Net Worth of ₹17.27 crore as of FY26. Established in 1985 and expanding into a 150-bed multi-specialty center offering 25 medical specialties, ABH Healthcare stands out as the No. 1 ranked hospital in Punjab by NHA and SHA (2022) among empaneled facilities. The hospital is among the top healthcare centers in India to receive the prestigious NABH Digital Accreditation (Silver Category). “Our mission has always been to bring high-quality, specialized healthcare within reach of communities in Tier-3 cities,” said Dr. Kamal Baghi, Chairman and Whole-time Director of ABH Healthcare Limited. “This IPO marks a momentous transition in our journey as we leverage public capital to optimize our balance sheet, expand our clinical capabilities into high-end programs like oncology and CTVS, and widen our footprint through asset-light delivery models.” Lead Managers & Key Intermediaries • Book Running Lead Manager (BRLM): Fedex Securities Pvt. Ltd. • Registrar to the Issue: Bigshare Services Pvt. Ltd. • Market Maker: Rikhav Securities Ltd. • IR & PR Partner: ORIM Connect About ABH Healthcare Limited ABH Healthcare Limited (operating Anil Baghi Hospital) is a leading regional healthcare provider headquartered in Ferozepur, Punjab. Offering advanced clinical care across critical care, interventional cardiology, neurosurgery, gastroenterology, orthopedics, and nephrology, the center is fully equipped with state-of-the-art diagnostic technology including MRI, Cardiac Cath Labs, and automated labs. The hospital has over 30 empanelments with major private and government health schemes, including Ayushman Bharat.
